Results 61 to 70 of about 1,985,761 (312)
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye +33 more
wiley +1 more source
Cancer Reports, 2022 Background The “accelerated” chronic lymphocytic leukemia (aCLL) is a relatively rare form of CLL progression. The expanded proliferation centers in aCLL have been associated with adverse prognostic features and propensity to more aggressive behavior ...
Leonid L. Yavorkovsky
doaj +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo +5 more
wiley +1 more source
Climate-change–driven accelerated sea-level rise detected in the altimeter era
Proceedings of the National Academy of Sciences of the United States of America, 2018 Significance Satellite altimetry has shown that global mean sea level has been rising at a rate of ∼3 ± 0.4 mm/y since 1993. Using the altimeter record coupled with careful consideration of interannual and decadal variability as well as potential ...
R. Nerem +5 more
semanticscholar +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Japan has one of the highest dialysis prevalence rates worldwide and a shrinking, aging population. Whether dialysis burden has entered a sustained post‐peak phase or whether recent declines partly reflect pandemic‐related disruptions remains uncertain.
Hatice Şahin +2 more
wiley +1 more source
Studi Efektivitas Program Akselerasi di SMU Surakarta
Jurnal Pendidikan dan Kebudayaan, 2010 This research is conducted with the purposes of 1) to get a thorough description of accelerated program in SMAN Surakarta, 2) To know the effectiveness of recruitment of prospective students in accelerated program in SMA Surakarta, 3) To know the degree
Munawir Yusuf
doaj +1 more source
Proceedings of the workshop on Speech and Natural Language - HLT '91, 1990 Our plan is to demonstrate a workstation accelerator (called PLUS) that not only executes the current speech recognition systems in real time, but that will also support the increasing computational demands of speech recognition systems for the next few years. The accelerator will also be useful for other compute bound applications.
openaire +4 more sources
Organoids in pediatric cancer research
FEBS Letters, EarlyView.Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley +1 more source
Comprehensive history of 3-year and accelerated US medical school programs: a century in review
Medical Education Online, 2018 Within the context of major medical education curricular reform ongoing in the United States, a subset of schools has re-initiated accelerated (3-year) medical education.
Christine C. Schwartz +3 more
doaj +1 more source
Gut microbiome and aging—A dynamic interplay of microbes, metabolites, and the immune system
FEBS Letters, EarlyView.Age‐dependent shifts in microbial communities engender shifts in microbial metabolite profiles. These in turn drive shifts in barrier surface permeability of the gut and brain and induce immune activation. When paired with preexisting age‐related chronic inflammation this increases the risk of neuroinflammation and neurodegenerative diseases.
Aaron Mehl, Eran Blacher
wiley +1 more source